Skip to main content
Log in

Expression of adenylate kinase fused MEK1R4F in Escherichia coli and its application in ERK phosphorylation

  • Original Research Paper
  • Published:
Biotechnology Letters Aims and scope Submit manuscript

Abstract

Objective

To construct a highly expressed and active MEK1R4F (a constitutively active form of mitogen-activated protein kinase kinase 1) by fusion of soluble adenylate kinase (Adk) tag, resulting in Adk-MEK1R4F protein suitable for preparation of phosphorylated ERK.

Results

We fused the Adk to the N-terminus of MEK1R4F through overlapping PCR. The expression of Adk-MEK1R4F fusion protein increased ~10-fold in Escherichia coli, and was purified to 95% via two purification steps including Ni–NTA and Q Sepharose fast flow (QFF) chromatography. The purified Adk-MEK1R4F protein was functional for ERK phosphorylation and could use ADP in addition to ATP. The Adk-MEK1R4F had higher catalytic activity than regular MEK1R4F both in vitro and in cell-free extracts system.

Conclusions

Adenylate kinase was used as a soluble tag to facilitate MEK1R4F protein expression and its application in large-scale phosphorylated ERK1/2 preparation and purification.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  • Abmayr SM, Carrozza MJ, Workman JL (2006) Preparation of nuclear and cytoplasmic extracts from mammalian cells. Curr Proto Pharmacol. doi:10.1002/0471142727.mb1201s75

    Google Scholar 

  • Alessi DR, Saito Y, Campbell DG, Cohen P, Sithanandam G, Rapp U, Ashworth A, Marshall CJ, Cowley S (1994) Identification of the sites in MAP kinase kinase-1 phosphorylated by p74raf-1. EMBO J 13:1610–1619

    CAS  PubMed  PubMed Central  Google Scholar 

  • Bârzu O, Michelson S (1983) Simple and fast purification of Escherichia coli adenylate kinase. FEBS Lett 153:280–284

    Article  PubMed  Google Scholar 

  • English JM, Cobb MH (2002) Pharmacological inhibitors of MAPK pathways. Trend Pharmacol Sci 23:40–45

    Article  CAS  Google Scholar 

  • Glaser M, Nulty W, Vagelos PR (1975) Role of adenylate kinase in the regulation of macromolecular biosynthesis in a putative mutant of Escherichia coli defective in membrane phospholipid biosynthesis. J Bacteriol 123:128–136

    CAS  PubMed  PubMed Central  Google Scholar 

  • Khokhlatchev AV, Canagarajah B, Wilsbacher J, Robinson M, Atkinson M, Goldsmith E, Cobb MH (1998) Phosphorylation of the MAP kinase ERK2 promotes its homodimerization and nuclear translocation. Cell 93:605–615

    Article  CAS  PubMed  Google Scholar 

  • Kupriyanov VV, Ferretti JA, Balaban RS (1986) Muscle adenylate kinase catalyzes adenosine 5′-tetraphosphate synthesis from ATP and ADP. Biochim Biophys Acta 869:107–111

    Article  CAS  PubMed  Google Scholar 

  • Liang P, Phillips GN, Glaser M (1991) Assignment of the nucleotide binding sites and the mechanism of substrate inhibition of Escherichia coli adenylate kinase. Prot Struct Funct Bioinform 9:28–36

    Article  CAS  Google Scholar 

  • Pearson G, Robinson F, Gibson TB, Xu BE, Karandikar M, Berman K, Cobb MH (2001) Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions. Endocrin Rev 22:153–183

    CAS  Google Scholar 

  • Peyssonnaux C, Eychène A (2001) The Raf/MEK/ERK pathway: new concepts of activation. Biol Cell 93:53–62

    Article  CAS  PubMed  Google Scholar 

  • Robinson MJ, Stippec SA, Goldsmith E, White MA, Cobb MH (1998) A constitutively active and nuclear form of the MAP kinase ERK2 is sufficient for neurite outgrowth and cell transformation. Curr Biol 8:1141–1152

    Article  CAS  PubMed  Google Scholar 

  • Sebolt-Leopold JS (2000) Development of anticancer drugs targeting the MAP kinase pathway. Oncogene 19:6594–6599

    Article  CAS  PubMed  Google Scholar 

  • Sebolt-Leopold JS, Herrera R (2004) Targeting the mitogen-activated protein kinase cascade to treat cancer. Nature Rev Cancer 4:937–947

    Article  CAS  Google Scholar 

  • Smith CK, Carr D, Mayhood TW, Jin W, Gray K, Windsor WT (2007) Expression and purification of phosphorylated and non-phosphorylated human MEK1. Prot Exp Purif 52:446–456

    Article  CAS  Google Scholar 

  • Wainstein E, Seger R (2016) The dynamic subcellular localization of ERK: mechanisms of translocation and role in various organelles. Curr Opin Cell Biol 39:15–20

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

This work was supported by the Natural Science Foundation of China (30970630 and 31270831), the Outstanding Youth Science Foundation of Chongqing (cstc2011jjjq10003), and the Program for New Century Excellent Talents in University (NCET-08-0912), the Fundamental Research Funds for the Central Universities (XDJK2016C158) and the Doctoral Fund of Southwestern University (XJKJXM003338).

Supporting information

Supplementary Table 1—The primers used to construct the protein expression plasmids.

Supplementary Table 2—Summary of His-Adk-MEK1R4F purification.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Hongtao Li.

Ethics declarations

Conflict of interest

The authors declare that they have no competing interests.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (DOCX 14 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Yang, F., Li, H. Expression of adenylate kinase fused MEK1R4F in Escherichia coli and its application in ERK phosphorylation. Biotechnol Lett 39, 1553–1558 (2017). https://doi.org/10.1007/s10529-017-2385-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10529-017-2385-3

Keywords

Navigation